ACTR8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.986600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.807800E-01
Normal-vs-Stage2
2.536000E-01
Normal-vs-Stage3
1.570020E-02
Normal-vs-Stage4
7.229400E-01
Stage1-vs-Stage2
9.949400E-01
Stage1-vs-Stage3
1.367560E-01
Stage1-vs-Stage4
1.781250E-01
Stage2-vs-Stage3
9.308300E-02
Stage2-vs-Stage4
7.459800E-02
Stage3-vs-Stage4
2.580300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.127600E-01
Normal-vs-AfricanAmerican
4.080600E-01
Normal-vs-Asian
9.714200E-02
Caucasian-vs-AfricanAmerican
8.783800E-01
Caucasian-vs-Asian
5.013800E-01
AfricanAmerican-vs-Asian
7.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.097800E-01
Normal-vs-Female
2.948400E-01
Male-vs-Female
6.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.942040E-01
Normal-vs-Age(41-60Yrs)
5.539600E-01
Normal-vs-Age(61-80Yrs)
2.190400E-01
Normal-vs-Age(81-100Yrs)
2.046600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.760400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.375800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.943800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.806300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.136000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.199200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.276450E-01
Normal-vs-Daily Drinker
4.829900E-02
Normal-vs-Weekly Drinker
2.354800E-01
Normal-vs-Occasional Drinker
6.134600E-01
Normal-vs-Social Drinker
6.850200E-01
Non Drinker-vs-Daily Drinker
6.148800E-01
Non Drinker-vs-Weekly Drinker
5.504600E-01
Non Drinker-vs-Occasional Drinker
8.707500E-02
Non Drinker-vs-Social Drinker
6.831900E-02
Daily Drinker-vs-Weekly Drinker
2.938000E-01
Daily Drinker-vs-Occasional Drinker
3.668400E-02
Daily Drinker-vs-Social Drinker
2.754300E-02
Weekly Drinker-vs-Occasional Drinker
3.547400E-01
Weekly Drinker-vs-Social Drinker
2.884000E-01
Occasional Drinker-vs-Social Drinker
8.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.006600E-01
Normal-vs-Grade 2
8.424300E-02
Normal-vs-Grade 3
5.566400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.048600E-01
Grade 1-vs-Grade 3
4.431400E-01
Grade 1-vs-Grade 4
3.006600E-01
Grade 2-vs-Grade 3
4.810400E-01
Grade 2-vs-Grade 4
8.424300E-02
Grade 3-vs-Grade 4
5.566400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.470600E-01
Normal-vs-NonDiabetic
2.484200E-01
Diabetic-vs-NonDiabetic
9.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.022400E-01
Normal-vs-NoPancreatitis
2.746600E-01
Pancreatitis-vs-NoPancreatitis
7.598000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.553200E-01
Normal-vs-N1
2.556600E-01
N0-vs-N1
5.273200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.666400E-01
Normal-vs-TP53-NonMutant
3.586600E-01
TP53-Mutant-vs-TP53-NonMutant
8.848000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
